Skip to content
★ Sign in to follow
MD

Michael D. Rogers

Executive
Pharmasset IncChimerix Inc
Total declarations
48
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (41 ops.)
€2.4M

Latest filing published 25 Mar 2015 for CHIMERIX INC, €45k.

Insider track record

Disclosed buys
0
Disclosed sells
41
Signal history

No signal scores available.

Michael D. Rogers: trading record in brief

This profile gathers the share dealings of Michael D. Rogers across 2 companies, led by Pharmasset Inc and Chimerix Inc. We count 48 filings; the first trade dates from 3 November 2008 and the latest from 23 March 2015.

The open-market record consists of 41 sales worth €2.4M, with no purchase. Outside the open market, there are 7 option exercises.

The newest entry dates from 25 March 2015: an option exercise of €45k, in Chimerix Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael D. Rogers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations48 total
  • ◇
    Chief Development OfficerExecutivesChimerix Inc
    48,236 USD0SEC
    6,372 shares@ US$7.57Common StockSEC:0001209191-15-029148:0
  • ◇
    Chief Development OfficerExecutivesChimerix Inc
    98,410 USD0SEC
    13,000 shares@ US$7.57Common StockSEC:0001144204-14-025656:0
  • ◇
    Chief Development OfficerExecutivesPharmasset Inc
    138,800 USD0SEC
    10,000 shares@ US$13.88Common Stock, $.001 par value per shareSEC:0001192482-11-000123:0
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    1M USD0SEC
    10,000 shares@ US$109.08Common Stock, $.001 par value per shareSEC:0001192482-11-000123:1
  • ◇
    Chief Development OfficerExecutivesPharmasset Inc
    277,600 USD0SEC
    20,000 shares@ US$13.88Common Stock, $.001 par value per shareSEC:0001192482-11-000108:0
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    2M USD0SEC
    20,000 shares@ US$99.00Common Stock, $.001 par value per shareSEC:0001192482-11-000108:1
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    7,448 USD0SEC
    400 shares@ US$18.62Common Stock, $.001 par value per shareSEC:0001192482-08-000402:0
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    1,863 USD0SEC
    100 shares@ US$18.63Common Stock, $.001 par value per shareSEC:0001192482-08-000402:1
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    13,074 USD0SEC
    701 shares@ US$18.65Common Stock, $.001 par value per shareSEC:0001192482-08-000402:2
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    9,326 USD0SEC
    499 shares@ US$18.69Common Stock, $.001 par value per shareSEC:0001192482-08-000402:3
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    5,610 USD0SEC
    300 shares@ US$18.70Common Stock, $.001 par value per shareSEC:0001192482-08-000402:4
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    5,613 USD0SEC
    300 shares@ US$18.71Common Stock, $.001 par value per shareSEC:0001192482-08-000402:5
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    19 USD0SEC
    1 shares@ US$18.72Common Stock, $.001 par value per shareSEC:0001192482-08-000402:6
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    11,250 USD0SEC
    600 shares@ US$18.75Common Stock, $.001 par value per shareSEC:0001192482-08-000402:7
  • ◇
    Chief Development OfficerExecutivesPharmasset Inc
    231,407 USD0SEC
    16,672 shares@ US$13.88Common Stock, $.001 par value per shareSEC:0001192482-08-000401:0
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    45,000 USD0SEC
    2,500 shares@ US$18.00Common Stock, $.001 par value per shareSEC:0001192482-08-000401:1
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    7,208 USD0SEC
    400 shares@ US$18.02Common Stock, $.001 par value per shareSEC:0001192482-08-000401:2
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    7,220 USD0SEC
    400 shares@ US$18.05Common Stock, $.001 par value per shareSEC:0001192482-08-000401:3
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    7,228 USD0SEC
    400 shares@ US$18.07Common Stock, $.001 par value per shareSEC:0001192482-08-000401:4
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    3,616 USD0SEC
    200 shares@ US$18.08Common Stock, $.001 par value per shareSEC:0001192482-08-000401:5
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    1,810 USD0SEC
    100 shares@ US$18.10Common Stock, $.001 par value per shareSEC:0001192482-08-000401:6
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    19,570 USD0SEC
    1,080 shares@ US$18.12Common Stock, $.001 par value per shareSEC:0001192482-08-000401:7
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    3,626 USD0SEC
    200 shares@ US$18.13Common Stock, $.001 par value per shareSEC:0001192482-08-000401:8
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    10,884 USD0SEC
    600 shares@ US$18.14Common Stock, $.001 par value per shareSEC:0001192482-08-000401:9
  • ▼
    Chief Development OfficerExecutivesPharmasset Inc
    2,184 USD0SEC
    120 shares@ US$18.20Common Stock, $.001 par value per shareSEC:0001192482-08-000401:10

25 of 48 declarations